Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Depreciation & Amortization (CF) (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Depreciation & Amortization (CF) for 3 consecutive years, with $539000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 146.12% to $539000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a 154.61% increase, with the full-year FY2025 number at $1.7 million, up 154.61% from a year prior.
  • Depreciation & Amortization (CF) was $539000.0 for Q4 2025 at Nuvation Bio, up from $534000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $539000.0 in Q4 2025 to a low of $55000.0 in Q3 2023.
  • A 3-year average of $220333.3 and a median of $190500.0 in 2024 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): rose 3.57% in 2024, then skyrocketed 434.48% in 2025.
  • Nuvation Bio's Depreciation & Amortization (CF) stood at $55000.0 in 2023, then skyrocketed by 298.18% to $219000.0 in 2024, then skyrocketed by 146.12% to $539000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Depreciation & Amortization (CF) are $539000.0 (Q4 2025), $534000.0 (Q3 2025), and $356000.0 (Q2 2025).